A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
Trial details
- Registry ID
- NCT03588975
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the KneeNCT03588975 | Vericel Corporation | Phase 3 | Recruiting | 2030-02Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |